Sterling Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-345,406
| Closed | -$1.02M | – | 930 |
|
|
2018
Q1 | $1.02M | Hold |
345,406
| – | – | 0.01% | 609 |
|
|
2017
Q4 | $946K | Hold |
345,406
| – | – | 0.01% | 648 |
|
|
2017
Q3 | $1.17M | Hold |
345,406
| – | – | 0.01% | 559 |
|
|
2017
Q2 | $853K | Buy |
+345,406
| New | +$853K | 0.01% | 663 |
|
|
2017
Q1 | – | Sell |
-204,916
| Closed | -$434K | – | 1059 |
|
|
2016
Q4 | $434K | Hold |
204,916
| – | – | ﹤0.01% | 794 |
|
|
2016
Q3 | $686K | Buy |
+204,916
| New | +$686K | 0.01% | 647 |
|
|
2015
Q3 | – | Sell |
-64,414
| Closed | -$414K | – | 1103 |
|
|
2015
Q2 | $414K | Sell |
64,414
-977
| -1% | -$6.28K | ﹤0.01% | 751 |
|
|
2015
Q1 | $460K | Sell |
65,391
-143,510
| -69% | -$1.01M | ﹤0.01% | 717 |
|
|
2014
Q4 | $1.61M | Sell |
208,901
-2,451
| -1% | -$18.9K | 0.01% | 490 |
|
|
2014
Q3 | $1.58M | Buy |
+211,352
| New | +$1.58M | 0.02% | 462 |
|
|
2014
Q2 | – | Sell |
-159,473
| Closed | -$1.33M | – | 1004 |
|
|
2014
Q1 | $1.33M | Buy |
159,473
+122,675
| +333% | +$1.02M | 0.01% | 490 |
|
|
2013
Q4 | $311K | Buy |
+36,798
| New | +$311K | ﹤0.01% | 717 |
|
|
2013
Q3 | – | Sell |
-40,986
| Closed | -$316K | – | 756 |
|
|
2013
Q2 | $316K | Buy |
+40,986
| New | +$316K | ﹤0.01% | 474 |
|